Concepedia
Statistics
Publications
55
Citations
3.4K
H-Index
31
Active since
1976
Affiliations
Max Delbrück Center(Current)
Charité - Universitätsmedizin Berlin
Bayer (Germany)
Helios Hospital Berlin-Buch
Medical University of Graz
Jens Hoffmann is an author at Max Delbrück Center specializing in medicine, oncology, and molecular oncology.
Publications per year
1976–2024
Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
Zoran Čulig, Jens Hoffmann, Martin Erdel et al. · British Journal of Cancer · 1999 · 421 citations · Full text
Medicine, Oncology, Pharmacology +17
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors
Moritz Schütte, Thomas S. Risch, Nilofar Abdavi-Azar et al. · Nature Communications · 2017 · 349 citations · Full text
Medicine, Molecular Medicine, Oncology +17
Establishment of Patient-Derived Non–Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers
Iduna Fichtner, Jana Rolff, Richie Soong et al. · Clinical Cancer Research · 2008 · 286 citations · Full text
Medicine, Oncology, Pharmacology +14
Regorafenib (BAY 73‐4506): Antitumor and antimetastatic activities in preclinical models of colorectal cancer
Roberta Schmieder, Jens Hoffmann, Michael W. Becker et al. · International Journal of Cancer · 2013 · 138 citations · Full text
Total Synthesis and Antitumor Activity of ZK‐EPO: The First Fully Synthetic Epothilone in Clinical Development
Ulrich Klar, Bernd Buchmann, Wolfgang Schwede et al. · Angewandte Chemie International Edition · 2006 · 126 citations
Medicine, Medicinal Chemistry, Pharmacology +10
1–5 of 55